Log In
Print
BCIQ
Print
Print this Print this
 

VXM01

  Manage Alerts
Collapse Summary General Information
Company Vaximm AG
DescriptionOral T cell vaccine targeting VEGFR-2
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today